...
首页> 外文期刊>Future medicinal chemistry >Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agents
【24h】

Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agents

机译:Pyrazoline scaffold: hit identification to lead synthesis and biological evaluation as antidiabetic agents

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Mining of novel scaffolds as potential DPP-IV inhibitors for future development of potential candidates as antidiabetic agents to address global issues. Methodology: The identified hit KB-10 from a previously reported study was taken as a lead for designing a library of analogues and screened initially based on in silico parameters and docking score. A series of selected (24-(1-acetyl-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenoxy-1-phenylethanone derivatives were synthesized and evaluated through in vitro studies. Compounds KB-23, KB-22 and KB-06 were found to be as potent, with IC50 values of 0.10 mu M, 0.12 mu M and 0.35 mu M, respectively. They also showed promising antihyperglycemic potential in in vivo studies (oral glucose tolerance tests) in Wistar rats. Conclusion: This work establishes pyrazoline analogues KB-23, KB-22 and KB-06 as promising starting points for the development of potential antidiabetic agents.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号